Announcements
- Immuron announces record Travelan® sales globally, Australia and USA
- Immuron requests pre-IND meeting for IMM-529 with FDA filing
- Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
- Immuron CEO Steven Lydeamore to present at Peak Sky High
- Immuron Board Changes
- Immuron Limited to Present at the Emerging Growth Conference
- Immuron Director Resignation
- Immuron to host Live Virtual Event
- Immuron Travelan® sales continued strong growth
- Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
More ▼
Key statistics
On Friday, Immuron Ltd (ANWA:DUS) closed at 2.10, 18.64% above the 52 week low of 1.77 set on Jul 08, 2024.
52-week range
Open | 2.06 |
---|---|
High | 2.18 |
Low | 2.06 |
Bid | 2.06 |
Offer | 2.22 |
Previous close | 2.10 |
Average volume | 0.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 26 2024 18:30 BST.
More ▼